Correction to "Protecting infants against RSV disease: an impact and cost-effectiveness comparison of long-acting monoclonal antibodies and maternal vaccination" [The Lancet Regional Health - Europe 38 (2024) 100829].

Autor:	Hodgson D; Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK., Wilkins N; UK Health Security Agency, London, UK., van Leeuwen E; Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.; UK Health Security Agency, London, UK., Watson CH; UK Health Security Agency, London, UK., Crofts J; UK Health Security Agency, London, UK., Flasche S; Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK., Jit M; Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK., Atkins KE; Centre of Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.; Centre for Global Health, Usher Institute, Edinburgh Medical School, University of Edinburgh, UK.
Jazyk:	angličtina
Zdroj:	The Lancet regional health. Europe [Lancet Reg Health Eur] 2024 Sep 11; Vol. 45, pp. 101073. Date of Electronic Publication: 2024 Sep 11 (Print Publication: 2024).
DOI:	10.1016/j.lanepe.2024.101073
Abstrakt:	[This corrects the article DOI: 10.1016/j.lanepe.2023.100829.]. (© 2024 Published by Elsevier Ltd.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu